Fluoropharma Medical Financials

FPMI Stock  USD 0.0001  0.00  0.00%   
We urge to utilize Fluoropharma Medical fundamental analysis to find out if markets are presently mispricing the company. Put another way you can exercise it to find out if Fluoropharma Medical is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We have collected data for twenty-five available fundamental indicators for Fluoropharma Medical, which can be compared to its peers. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of Fluoropharma Medical to be traded at $1.0E-4 in 90 days.
  
Understanding current and past Fluoropharma Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Fluoropharma Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Fluoropharma Medical's assets may result in an increase in income on the income statement.

Fluoropharma Medical Stock Summary

Fluoropharma Medical competes with Salarius Pharmaceuticals, Corvus Pharmaceuticals, Mereo BioPharma, Affimed NV, and BioNTech. FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey. Fluoropharma Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS3438701019
Business Address8 Hillside Avenue,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.fluoropharma.com
Phone973 744 1565
CurrencyUSD - US Dollar

Fluoropharma Medical Key Financial Ratios

Fluoropharma Medical's financial ratios allow both analysts and investors to convert raw data from Fluoropharma Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Fluoropharma Medical over time and compare it to other companies across industries.

Fluoropharma Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Fluoropharma Medical's current stock value. Our valuation model uses many indicators to compare Fluoropharma Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fluoropharma Medical competition to find correlations between indicators driving Fluoropharma Medical's intrinsic value. More Info.
Fluoropharma Medical is rated below average in return on asset category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Fluoropharma Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Fluoropharma Medical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Fluoropharma Medical Systematic Risk

Fluoropharma Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Fluoropharma Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Fluoropharma Medical correlated with the market. If Beta is less than 0 Fluoropharma Medical generally moves in the opposite direction as compared to the market. If Fluoropharma Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Fluoropharma Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Fluoropharma Medical is generally in the same direction as the market. If Beta > 1 Fluoropharma Medical moves generally in the same direction as, but more than the movement of the benchmark.

Complementary Tools for Fluoropharma Pink Sheet analysis

When running Fluoropharma Medical's price analysis, check to measure Fluoropharma Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fluoropharma Medical is operating at the current time. Most of Fluoropharma Medical's value examination focuses on studying past and present price action to predict the probability of Fluoropharma Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fluoropharma Medical's price. Additionally, you may evaluate how the addition of Fluoropharma Medical to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device